{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:10:22Z","timestamp":1790665822241,"version":"4.1.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Pediatric acute-onset neuropsychiatric syndrome (PANS) is a descriptive clinical entity defined by the abrupt onset of psychiatric and somatic symptoms leading to significant loss of function. Data on well-characterized PANS patients are limited, biomarkers have yet to be identified, and a solid evidence base to guide treatment is lacking. In this study, we present our experience of a systematic evaluation of the first 45 patients included in a Swedish cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>During the period 2014\u20132018, our clinic received 100 referrals regarding suspected PANS. All patients underwent a standardized psychiatric\/medical evaluation by a child\/adolescent psychiatrist and a clinical psychologist or a nurse. Those with severe symptoms were also assessed by a pediatric neurologist and a pediatric rheumatologist. Laboratory tests were obtained at different time points in an attempt to capture an active disease state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 100 referrals, 45 met strict PANS criteria and consented to participate in a long-term follow-up study. The median age at intake was 7.2 years (range 3.0\u201313.1) and 56% were male. Ninety-three percent fulfilled both criteria for acute\/atypical onset of PANS symptoms and having had an infection in relation to onset. Sixteen percent had an onset of an autoimmune or inflammatory disorder in temporal relation to the onset of PANS-related symptoms. The most common onset symptoms were obsessive-compulsive disorder (89%), anxiety (78%), and emotional lability (71%). Twenty-four percent had a preexisting autoimmune disease (AD) and 18% a preexisting psychiatric\/neuropsychiatric diagnosis. Sixty-four percent of biological relatives had at least one psychiatric disorder and 76% at least one AD or inflammatory disorder. Complement activation (37%), leukopenia (20%), positive antinuclear antibodies (17%), and elevated thyroid antibodies (11%) were the most common laboratory findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In our PANS cohort, there was a strong indication of an association with AD. Further work is needed to establish whether any of the potential biomarkers identified will be clinically useful. Long-term follow-up of these patients using the Swedish national registers will enable a deeper understanding of the course of this patient group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2018.0127","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T16:13:12Z","timestamp":1559837592000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":57,"title":["Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet"],"prefix":"10.1177","volume":"29","author":[{"given":"Caroline","family":"Gromark","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden."},{"name":"BUP OCD and Related Disorders, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."},{"name":"Centre for Psychiatry Research, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden."},{"name":"Division of Pediatric Neurology, Karolinska University Hospital, Solna, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaCarin","family":"Horne","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden."},{"name":"Division of Pediatric Rheumatology, Karolinska University Hospital, Solna, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Silverberg-M\u00f6rse","sequence":"additional","affiliation":[{"name":"BUP OCD and Related Disorders, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serlachius","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden."},{"name":"Centre for Psychiatry Research, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mataix-Cols","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden."},{"name":"BUP OCD and Related Disorders, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."},{"name":"Centre for Psychiatry Research, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th ed. Washington DC: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.091"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.56"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0139"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0193"},{"key":"e_1_3_4_7_1","first-page":"28","article-title":"The clinical global impressions scale: Applying a research tool in clinical practice","volume":"4","author":"Busner J","year":"2007","unstructured":"Busner J, , Targum SD: The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry, 4:28\u201332, 2007.","journal-title":"Psychiatry"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0084"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0151"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/fnl.16.4"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812451327"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"e_1_3_4_13_1","first-page":"136","article-title":"Detection of upper limit of normal values of anti-DNase B antibody in children's age groups who were admitted to hospital with noninfectious reasons","volume":"2","author":"Delice S","year":"2015","unstructured":"Delice S, , Adaleti R, , Sevan S, , Alagoz P, , Bedel A, , Nuhoglu C, , Aksaray S: Detection of upper limit of normal values of anti-DNase B antibody in children's age groups who were admitted to hospital with noninfectious reasons. North Clin Istanb, 2:136\u2013141, 2015.","journal-title":"North Clin Istanb"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2016.08.008"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0081"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0148"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.04.035"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09395"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110048007"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5431-9"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303807"},{"key":"e_1_3_4_22_1","first-page":"164","article-title":"Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis","volume":"33","author":"Harel L","year":"2006","unstructured":"Harel L, , Prais D, , Uziel Y, , Mukamel M, , Hashkes P, , Harel G, , Amir J, , Monselise Y, , Press J: Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol, 33:164\u2013166, 2006.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.09.002"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.11.001"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.23.1.jnp90"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003038"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.11.020"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000348388"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2657"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0080"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2010.10.011"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198907000-00015"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2016.10.034"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0153"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-8-27"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.215"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.12.017"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005474"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-43"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e318247b87d"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2017-000074"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.09.025"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.07.017"},{"key":"e_1_3_4_44_1","unstructured":"Roche Diagnostics GmbH: Reference Intervals for Children and Adults: Elecsys Thyroid Tests. www.roche.com 2009."},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790100074010"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.01.001"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0179"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0018492"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.2.264"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0145"},{"key":"e_1_3_4_51_1","first-page":"153","article-title":"Prevalence of positive antinuclear antibodies in healthy children","volume":"23","author":"Wananukul S","year":"2005","unstructured":"Wananukul S, , Voramethkul W, , Kaewopas Y, , Hanvivatvong O: Prevalence of positive antinuclear antibodies in healthy children. Asian Pac J Allergy Immunol, 23:153, 2005.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2016.06.017"},{"key":"e_1_3_4_53_1","unstructured":"World Health Organization: International Statistical Classification of Diseases and Related Health Problems\u2014Tenth Revision. Geneva Switzerland Elsevier Limited 2011."},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.063"},{"key":"e_1_3_4_55_1","first-page":"301","article-title":"Use of vitamin D in children and adults: Frequently asked questions","volume":"10","author":"Yesiltepe Mutlu G","year":"2018","unstructured":"Yesiltepe Mutlu G, , Hatun S: Use of vitamin D in children and adults: Frequently asked questions. J Clin Res Pediatr Endocrinol, 10:301\u2013306, 2018.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5788-9"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2018.0127","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2018.0127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2018.0127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:55:32Z","timestamp":1777388132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2018.0127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1089\/cap.2018.0127"],"URL":"https:\/\/doi.org\/10.1089\/cap.2018.0127","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}